Manufacturer
Seqirus
Pharmaceutical manufacturer based in Australia
Australia
- Products listed
- 2
- Molecules
- 2
- Therapy areas
- 0
Seqirus is a pharmaceutical manufacturer based in Australia. MedsAcross lists 2 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Australia
- Indian manufacturer
- No
- Also listed as
- Seqirus GmbH, Seqirus Inc., Seqirus S.r.l., Seqirus, Inc.
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Seqirus products through licensed channels, with the documents your regulator needs.
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Fluad injectable suspensionIntramuscular | Influenza a virus a/missouri/11/2025 ivr-279 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 ivr-285 (h3n2) antigen (formaldehyde inactivated), influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | US FDA | Available on request |
| Flucelvax injectable suspensionIntramuscular | Influenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated) | US FDA | Available on request |
Molecules made
Influenza a virus a/missouri/11/2025 ivr-279 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 ivr-285 (h3n2) antigen (formaldehyde inactivated), influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)Influenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated)
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Seqirus
Send a request for any of these products. We confirm the licensed source, documents and lead time.